Pricing Log in Create free account

Alkermes plc (ALKS) vs Elanco Animal Health Incorporated (ELAN)

Alkermes plc and Elanco Animal Health Incorporated are both Drug Manufacturers Specialty & Generic companies. Elanco Animal Health Incorporated is the larger, with a market value of $11.8B against $7.5B — 1.6× the size. Alkermes plc grew revenue faster over the last twelve months: 15.3% against 12.0%. Alkermes plc has the higher net margin (−0.02% vs −3.96%) and the higher return on invested capital (1.54% vs 0.51%). Across the 20 metrics below, Alkermes plc leads on 14 and Elanco Animal Health Incorporated on 6.

Valuation

Metric ALKS ELAN Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 4.27 2.36 2.08
P/B 4.02 1.80 1.79
Price to free cash flow 32.78 33.22 16.29
EV/EBITDA 37.88 19.70 12.22
EV/Sales 4.69 3.04 2.87
Earnings yield 0.00% (1.73%) (15.94%)
Free cash flow yield 3.05% 3.01% 0.00%

Profitability

Metric ALKS ELAN Drug Manufacturers Specialty & Generic median
Gross margin 82.89% 55.36% 53.51%
Operating margin 3.66% 1.61% 0.00%
Net margin (0.02%) (3.96%) (2.45%)
Free cash flow margin 13.03% 7.55% 0.00%
Return on equity (0.02%) (2.98%) (0.80%)
Return on assets (0.01%) (1.46%) (1.67%)
Return on invested capital 1.54% 0.51% 0.00%

Growth

Metric ALKS ELAN Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 15.27% 11.95% 5.22%
EPS growth (last fiscal year) (34.10%) (169.12%) 42.91%
Revenue growth, 5-year CAGR 7.28% 7.59% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALKS ELAN Drug Manufacturers Specialty & Generic median
Debt to equity 0.80 0.59 0.04
Current ratio 2.42 2.05 2.41
Net debt to EBITDA (4.69) 5.00 1.01

Dividend

Metric ALKS ELAN Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ALKS ELAN Drug Manufacturers Specialty & Generic median
Market cap 7.48b 11.83b 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack